Latest Rosalind Advisors, Inc. Stock Portfolio
$269Million | No. of Holdings #29
Rosalind Advisors, Inc. Performance
2026 Q2+14.73%
YTD+2.17%
2025+14.98%
About Rosalind Advisors, Inc. and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Rosalind Advisors, Inc. reported an equity portfolio of $269.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Rosalind Advisors, Inc. are DCTH, FENC, XERS. The fund has invested 15.4% of it's portfolio in DELCATH SYSTEMS, INC. and 12.7% of portfolio in FENNEC PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off CG ONCOLOGY INC, VIRIDIAN THERAPEUTICS INC (VRDN) and LIPOCINE INC (LPCN) stocks. They significantly reduced their stock positions in ONKURE THERAPEUTICS INC, CELLDEX THERAPEUTICS INC (CLDX) and POLYPID LTD (PYPD). Rosalind Advisors, Inc. opened new stock positions in ABIVAX SA, SPRUCE BIOSCIENCES INC (SPRB) and PEPGEN INC (PEPG). The fund showed a lot of confidence in some stocks as they added substantially to REGENTIS BIOMATERIALS LTD, VERASTEM INC (VSTM) and TALPHERA INC (ACRX).
Rosalind Advisors, Inc. Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$269Million
as of Aug 14, 2026Rosalind Advisors, Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Rosalind Advisors, Inc. made a return of 14.73% in the last quarter. In trailing 12 months, it's portfolio return was 36.34%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| abivax sa | 2,781,000 |
| spruce biosciences inc | 1,080,000 |
| pepgen inc | 630,000 |
New stocks bought by Rosalind Advisors, Inc.
Additions
| Ticker | % Inc. |
|---|---|
| regentis biomaterials ltd | 178 |
| verastem inc | 86.42 |
| neuraxis inc | 77.56 |
| talphera inc | 54.13 |
| cybin inc | 27.74 |
| fennec pharmaceuticals inc | 9.62 |
| biofrontera inc | 9.59 |
Additions to existing portfolio by Rosalind Advisors, Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| onkure therapeutics inc | -66.2 |
| celldex therapeutics inc | -39.39 |
| polypid ltd | -34.87 |
| vaxcyte inc | -31.03 |
| biocryst pharmaceuticals inc | -21.84 |
| xeris biopharma holdings inc | -9.99 |
| atea pharmaceuticals inc | -8.64 |
| vor biopharma inc | -7.34 |
Rosalind Advisors, Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| viridian therapeutics inc | -4,897,840 |
| lipocine inc | -1,770,710 |
| annexon inc | -1,108,000 |
| definium therapeutics inc | -2,362,500 |
| cg oncology inc | -6,768,000 |
| avalo therapeutics inc | -1,119,750 |
Rosalind Advisors, Inc. got rid off the above stocks
Sector Distribution
Rosalind Advisors, Inc. has about 84.8% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 84.8 |
| Others | 15.2 |
Market Cap. Distribution
Rosalind Advisors, Inc. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- UNALLOCATED
- MID-CAP
- NANO-CAP
- MICRO-CAP
| Category | % |
|---|---|
| SMALL-CAP | 69.4 |
| UNALLOCATED | 15.2 |
| MID-CAP | 9.9 |
| NANO-CAP | 2.9 |
| MICRO-CAP | 2.6 |
Stocks belong to which Index?
About 57.8% of the stocks held by Rosalind Advisors, Inc. either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 57.8 |
| Others | 42.2 |
Rosalind Advisors, Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Rosalind Advisors, Inc.
Rosalind Advisors, Inc. has 29 stocks in it's portfolio. About 74% of the portfolio is in top 10 stocks. VSTM proved to be the most loss making stock for the portfolio. FENC was the most profitable stock for Rosalind Advisors, Inc. last quarter.
$266.23MTotal Value
35.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Talphera Inc Talphera IncACRX Rosalind Advisors, Inc.'s holding in Talphera Inc over time | 1.98% | 5,169,500 | $5.32M 1.98% | 54.13%increased 54.13 percentadded | |
 Annexon Inc Annexon IncANNX Rosalind Advisors, Inc.'s holding in Annexon Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Aquestive Therapeutics Inc Rosalind Advisors, Inc.'s holding in Aquestive Therapeutics Inc over time | 0.39% | 250,000 | $1.04M 0.39% | 0%unchanged 0 percentunchanged | |
 Atea Pharmaceuticals Inc Rosalind Advisors, Inc.'s holding in Atea Pharmaceuticals Inc over time | 1.85% | 1,070,550 | $4.98M 1.85% | 8.64%decreased 8.64 percentreduced | |
 Avalo Therapeutics Inc Rosalind Advisors, Inc.'s holding in Avalo Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Biocryst Pharmaceuticals Inc Rosalind Advisors, Inc.'s holding in Biocryst Pharmaceuticals Inc over time | 2.68% | 721,504 | $7.22M 2.68% | 21.84%decreased 21.84 percentreduced | |
 Biofrontera Inc Biofrontera IncBFRI Rosalind Advisors, Inc.'s holding in Biofrontera Inc over time | 0.45% | 1,275,610 | $1.21M 0.45% | 9.59%increased 9.59 percentadded | |
 Celldex Therapeutics Inc Rosalind Advisors, Inc.'s holding in Celldex Therapeutics Inc over time | 2.76% | 200,000 | $7.44M 2.76% | 39.39%decreased 39.39 percentreduced | |
 CYBN Cybin IncCybin IncCYBN | 4.8% | 1,956,810 | $12.93M 4.8% | 27.74%increased 27.74 percentadded | |
 Delcath Systems, Inc. Rosalind Advisors, Inc.'s holding in Delcath Systems, Inc. over time | 15.44% | 3,300,390 | $41.55M 15.44% | 0%unchanged 0 percentunchanged | |
 Eyepoint Pharmaceuticals Inc Rosalind Advisors, Inc.'s holding in Eyepoint Pharmaceuticals Inc over time | 5.25% | 988,230 | $14.13M 5.25% | 4.68%decreased 4.68 percentreduced | |
 Fennec Pharmaceuticals Inc Rosalind Advisors, Inc.'s holding in Fennec Pharmaceuticals Inc over time | 12.73% | 3,188,000 | $34.27M 12.73% | 9.62%increased 9.62 percentadded | |
 Kura Oncology Inc Rosalind Advisors, Inc.'s holding in Kura Oncology Inc over time | 0.41% | 100,000 | $1.10M 0.41% | 0%unchanged 0 percentunchanged | |
 Lipocine Inc Lipocine IncLPCN Rosalind Advisors, Inc.'s holding in Lipocine Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 MDWD Mediwound LtdMediwound LtdMDWD | 4.09% | 749,054 | $11.01M 4.09% | 0%unchanged 0 percentunchanged | |
| 1.41% | 3,637,890 | $3.78M 1.41% | 5.44%decreased 5.44 percentreduced | ||
 Inspiremd Inc Inspiremd IncNSPR Rosalind Advisors, Inc.'s holding in Inspiremd Inc over time | 1.02% | 3,905,740 | $2.73M 1.02% | 0%unchanged 0 percentunchanged | |
 Ovid Therapeutics Inc Rosalind Advisors, Inc.'s holding in Ovid Therapeutics Inc over time | 1.11% | 1,107,990 | $2.98M 1.11% | 0%unchanged 0 percentunchanged | |
 Vaxcyte Inc Vaxcyte IncPCVX Rosalind Advisors, Inc.'s holding in Vaxcyte Inc over time | 4.32% | 200,000 | $11.63M 4.32% | 31.03%decreased 31.03 percentreduced | |
 Pepgen Inc Pepgen IncPEPG Rosalind Advisors, Inc.'s holding in Pepgen Inc over time | 0.23% | 350,000 | $630.0K 0.23% | Newnew position | |
